What outcome should the nurse monitor for after administering loteprednol to a postoperative ophthalmic surgery patient?

• A. Lowered intraocular pressure in affected eye.
• B. Reduced postoperative pain and inflammation.
• C. Promotion of the flow of tears through the lacrimal duct.
• D. Decreased risk for superficial infection caused by surgery.

Answer: (B)

After administering loteprednol to a postoperative ophthalmic surgery patient, monitoring for reduced postoperative pain and inflammation should be a priority. Loteprednol is a corticosteroid that alleviates discomfort and mitigates the inflammatory response post-surgery. By suppressing inflammatory mediators, it helps manage symptoms such as swelling, redness, and discomfort that can follow ophthalmic procedures.

When looking at the other options, while lowered intraocular pressure and decreased infection risk are important considerations in ophthalmic care, loteprednol primarily focuses on reducing inflammation and pain rather than directly impacting intraocular pressure or infection control. Similarly, promoting tear flow is not a primary function of loteprednol; its main role is to address inflammation and associated discomfort. Therefore, observation of pain relief and reduced inflammation is the most appropriate outcome to monitor after the administration of loteprednol.